Kinetochore-associated protein 2 (KNTC2), also known to be highly expressed in cancer 1 (HEC1), is elevated in gastric cancer, colorectal cancer, prostate cancer, and many other tumors; tumor growth is inhibited when KNTC2 is downregulated [7–9]. This evidence concerns the gene NDC80 and colorectal cancer.